|
NCCN Tumor Boards: Management of Early-Stage, Invasive, Non-Metastatic Breast Cancer |
1.00 |
08/07/2026 - 12:00am to 01/17/2027 - 11:59pm |
|
NCCN Guidelines® Insights - Survivorship, Version 3.2026 |
1.00 |
08/10/2026 - 12:00am to 08/10/2027 - 11:59pm |
|
Archived NCCN Tumor Boards: Molecularly Guided Treatment of Adult Gliomas |
1.00 |
08/13/2026 - 12:00am to 08/07/2027 - 11:59pm |
|
Team Strategies for Overcoming Challenges to Guideline-Concordant Care of High-Risk HR-Positive/HER2-Negative Early Breast Cancer |
1.00 |
09/01/2026 - 12:00am to 02/28/2027 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - Precision Immune Targeting: The Rise of Bispecifics in Multiple Myeloma |
1.00 |
09/03/2026 - 12:00am to 01/31/2027 - 11:59pm |
|
Recorded Presentation of NCCN Optimizing Patient Outcomes - Small Cell Lung Cancer: Is Immunotherapy Moving the Needle? |
1.00 |
09/09/2026 - 12:00am to 09/03/2027 - 11:59pm |
Facebook
X
LinkedIn
Forward